Brentview Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Buy
42,671
+1,625
+4% +$156K 1.6% 35
2025
Q4
$3.94M Buy
41,046
+216
+0.5% +$21K 1.78% 33
2025
Q3
$3.89M Buy
40,830
+1,311
+3% +$121K 1.77% 32
2025
Q2
$3.44M Sell
39,519
-764
-2% -$64.8K 1.74% 33
2025
Q1
$3.62M Buy
40,283
+2,025
+5% +$181K 1.93% 28
2024
Q4
$3.06M Buy
+38,258
New +$3.31M 1.74% 29

Other funds holding MDT

Brentview Investment Management's MDT Position: Q1 2026 in Review

Brentview Investment Management increased its Medtronic (MDT) stake by 4% in Q1 2026, buying an estimated $156K and bringing the position to 42,671 shares worth $3.7M. The position accounts for 1.6% of the portfolio, ranked #35.

Brentview Investment Management first reported a position in MDT in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.94M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Brentview Investment Management held 42,671 shares of Medtronic worth $3.7M as of Q1 2026.
  • Brentview Investment Management bought 1,625 Medtronic shares in Q1 2026, an estimated $156K.
  • Medtronic made up 1.6% of Brentview Investment Management's portfolio in Q1 2026, its #35 holding.
  • Brentview Investment Management first reported a position in Medtronic in Q4 2024 and has held it in 6 quarters since.
  • Brentview Investment Management's Medtronic position peaked at $3.94M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Brentview Investment Management's 13F filing for Q1 2026, filed 14 May 2026.